Prevalence of HCV Antibodies Among Haemodialysis Patients In Qena Governorate Sector (B)

Abstract

This study is a part of project modulated by Ain shams university, nephrology department to survey the prevalence of HCV among HD patients.

The study was done upon 866 patients,( 527 male 60.9%-339 female 39.1% ) at 15 HD units in Qena governorate.

The study was done in the following units: ( Qena general hospital, Elhelal Elahmer hospital, Qena fever hospital, Elyom Elwahd hospital, Naghamady hospital, Elmosah hospital, Elwakf hospital, Keft hospital, Barahmaa hospital, koss hospital, Nakada hospital, Armant hospital, Abotesht hospital, Farshot hospital, Deshnaa hospital ).

All patients were evaluated using a questionnaire form for assessment of risk factors claimed to be responsible for HCV seroconvergence among HD patients such as: (age, sex, HCV at start of HD, timing of seroconversion, duration of HD, previous blood transfusion, previous surgery, isolation procedures of place-machine & staff, infection control measures, switch of patients between dialysis centers, vascular access, history of bilhareseasis, , history of hepatitis B).

The prevalence of HCV Ab at the start of dialysis was (26.1%), & the prevalence of HCV Ab by the time of data collection was (46.3%) with a rate of seroconversion of (27.34%), after a mean duration of HD since starting dialysis of 3.62 year. The study revealed that there is no significant relation between sex ,family history of HCV , previous blood transfusion ,previous surgery , isolation procedures ,infection control measures, history of schistosomiasis and transmission of HCV.